23
项与 盐酸伊立替康脂质体(石药集团欧意药业) 相关的临床试验Single-arm, multicenter, exploratory clinical study of irinotecan liposomes combined with oxaliplatin and 5-Fu/Lv in second-line treatment of locally advanced or metastatic pancreatic cancer
Phase I clinical study of irinotecan liposome combined with furoquininib in the third-line and beyond patients with advanced colorectal cancer
Clinical study of Irinotecan liposomes combined with Tigorgone for the treatment of patients with advanced metastatic pancreatic cancer with liver metastasis of second line and above
100 项与 盐酸伊立替康脂质体(石药集团欧意药业) 相关的临床结果
100 项与 盐酸伊立替康脂质体(石药集团欧意药业) 相关的转化医学
100 项与 盐酸伊立替康脂质体(石药集团欧意药业) 相关的专利(医药)
100 项与 盐酸伊立替康脂质体(石药集团欧意药业) 相关的药物交易